Expertise and Research Interests
Modalities for Speech and Swallowing Rehabilitation, Neuromuscular Electrical Stimulation (NMES), Surface Electromyography (sEMG) and Neuromuscular Taping
Modalities for Speech and Swallowing Rehabilitation, Neuromuscular Electrical Stimulation (NMES), Surface Electromyography (sEMG) and Neuromuscular Taping
Marissa.Barrera@yu.edu I 205 Lexington Avenue, 7th FL, NYC
Dr. Marissa A. Barrera is an internationally recognized medical Speech-Language Pathologist and Multiple Sclerosis Certified Specialist. She is a licensed speech-language pathologist (NY/NJ) & Multiple Sclerosis Certified Specialist (MSCS) with extensive training in the evaluation & treatment of individuals with neurological conditions. She is a recognized expert on the use of modalities (NMES, sEMG, neuromuscular taping, ultrasound) for speech and swallowing rehabilitation and provides clinical training courses globally.
As a researcher and author, Dr. Barrera has lectured in over 15 countries on a wide array of clinical topics ranging from dysphagia, NMES, motor speech disorders, cognition and neurogenerative diseases. She has several peer reviewed publications and over 80 research abstracts. She has been featured in Women’s Health, Vice Magazine, ADVANCE for Speech-Language Pathology and MTV’s Funny or Die. For the past 10 years Dr. Barrera has enjoyed serving as an expert medical witness in addition to providing comprehensive IME evaluations. Dr. Barrera has previously worked in a variety of settings including, hospitals, outpatient rehab, home care & private practice.
Dr. Barrera serves as the Assistant Dean of Health Sciences as well as the Program Director at Yeshiva University's Graduate Program in Speech-Language Pathology at the Katz School of Science and Health. She is a member of the prestigious Clinical Advisory Committee of the National MS Society and the Multiple Sclerosis Foundation Advisory Board. In 2010, she was the recipient of the MS Rehabilitation Fellowship and since 2012, Dr. Barrera has served as distinguished faculty for the Consortium of MS Centers. In 2019, Dr. Barrera was awarded the Healthcare Professional Champion award from the National MS Society. Dr. Barrera is also the founder and owner of the New York Neurogenic Speech-Language Pathology.
“Speech-language pathologists bring a specialized lens, particularly when it comes to communication and cognition, that is absolutely essential.”
“Effective clinical care is not about fixing or forcing—it’s about creating space, honoring each patient’s pace and believing that every form of communication is meaningful."
“We’re training speech-language pathologists who are prepared to meet the most complex clinical needs. That includes patients with Parkinson’s, traumatic brain injury and other neurological disorders.”
-- Dr. Marissa Barrera
Primarily works with individuals with Multiple Sclerosis, however, actively treats patients with Parkinson’s Disease, Aphasia, Traumatic Brain Injury, Dementia, Primary Progressive Aphasia, Alzheimer’s Disease, Spinal Cord Injury, Progressive Supranuclear Palsy, Huntington’s Disease, Myasthenia Gravis, and Amyotrophic Lateral Sclerosis. Expert medical witness, IME evaluations.
Dr. Barrera said Smith’s work is a powerful call to action.
At the Katz School’s Graduate Symposium on Science, Technology and Health, Brooke Smith, a student in the M.S. in Speech-Language Pathology, explored an overlooked frontier in veteran rehabilitation: the cognitive communication impairments that shadow Post-Traumatic Stress Disorder (PTSD).
Her research, “Cognitive Crossroads: PTSD, Executive Function, and the Role of the Medical Speech-Language Pathologists,” used a mixed-methods approach, systematically reviewing literature, including a meta-analysis of 18 studies involving over 1,000 participants, including 422 individuals diagnosed with PTSD. The findings were clear: across the board, PTSD significantly impaired executive function when compared with both trauma-exposed and healthy control groups.
Group therapy may hold untapped potential.
At the recent Graduate Symposium on Science, Technology and Health, Sharon Matalon, a student in the M.S. in Speech-Language Pathology, presented findings that could reshape how clinicians approach articulation therapy for children with Autism Spectrum Disorder (ASD). Her research, “Maximizing Speech Outcomes in Children with ASD: Group vs. Individual Therapy,” tackles a vital question in speech-language pathology: Can group therapy be just as effective as individual therapy, and under what circumstances?
Giordano enrolled at the Katz School not just with a dream but with a mission.
In a bright therapy room filled with toys, Kasey Giordano waits with quiet determination. She doesn’t speak. She doesn’t prompt. She doesn’t rush to fill the silence. She waits—10 seconds, 12 seconds—until the young boy across from her, a child with autism and minimal verbal skills, meets her gaze, looks at the bubbles in her hand, then back at her again. He doesn’t say the word “more,” not yet. But his body speaks for him. And for Giordano, a student in the M.S. in Speech-Language Pathology, that small exchange is nothing short of profound.